EV/EBITDA
-0.48
+0.02+4.00%
Mon, 03 Mar 2025 22:20:52 GMT
Summary
- As of March 4, 2025, CTCX EV/EBITDA is -0.48, with a rise of +0.02 (+4.00%) during the most recent trading day.
- Over the past year, CTCX EV/EBITDA has increased by +4.53 (+90.42%).
- CTCX EV/EBITDA is now -50.00% below its all-time high of -0.32.
Performance
CTCX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CTCX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +4.0% | -4.3% | -4.0% |
| 1 m1 month | +34.3% | -34.5% | -32.8% |
| 3 m3 months | +32.4% | -32.5% | -30.9% |
| 6 m6 months | +20.0% | -50.8% | -53.9% |
| ytdytd | +17.2% | -17.1% | -16.0% |
| 1 y1 year | +90.4% | -94.0% | -92.9% |
| 5 y5 years | - | - | - |
CTCX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -4.3% | -0.73 | +34.3% | |
| 3 m | 3-month | -0.43 | -11.6% | -1.34 | +64.2% |
| 6 m | 6-month | -0.32 | -50.0% | -1.46 | +67.1% |
| 1 y | 1-year | -0.32 | -50.0% | -5.01 | +90.4% |
| 3 y | 3-year | -0.32 | -50.0% | -13.62 | +96.5% |
| 5 y | 5-year | -0.32 | -50.0% | -13.62 | +96.5% |
| alltime | all time | -0.32 | -50.0% | -13.62 | +96.5% |
Carmell Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.48(-17.2%) |
| Date | Value |
|---|---|
| 2024 | -0.58(-89.9%) |
| 2023 | -5.77 |
FAQ
- What is Carmell Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Carmell Therapeutics?
- What is CTCX EV/EBITDA year-to-date change?
- What is Carmell Therapeutics EV/EBITDA year-on-year change?
What is Carmell Therapeutics EV/EBITDA?
The current EV/EBITDA of CTCX is -0.48
What is the all time high EV/EBITDA for Carmell Therapeutics?
Carmell Therapeutics all-time high EV/EBITDA is -0.32
What is CTCX EV/EBITDA year-to-date change?
Carmell Therapeutics EV/EBITDA has changed by +0.10 (+17.24%) since the beginning of the year
What is Carmell Therapeutics EV/EBITDA year-on-year change?
Over the past year, CTCX EV/EBITDA has changed by +4.53 (+90.42%)